2nd Annual Precision Genomic Medicine Conference 2019
Precision Genomic Medicine utilizes an individual’s genome profile as a tool in managing patient health care. This rapidly growing field holds great promise in evolving medicine toward tailored treatments through integrative medicine, science, and technology, but it requires an underlying broad knowledge base by both the health care provider and the patient.
This educational event will provide health care professionals an introduction to the current areas of study, cases where Precision Genomic Medicine (PGM) is already employed in clinical practice, appraise what PGM can - and cannot - do, and possible benefits and challenges surrounding its implementation in standard practice. With the knowledge base gained from this conference, the health care provider should be able to decide if genomic information should be considered in their patient’s treatment.
Date: Thursday, May 2, 2019
Location: Pediatrics Conference Center, 2415 Colloton Pavilion (2nd level, by Elevator E)
Click here for a map of the University of Iowa Hospitals and Clinics and parking information
Continuing Medical Education Credit: The University of Iowa Carver College of Medicine designates this live activity for a maximum of 5.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The University of Iowa Roy J. and Lucille A. Carver College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Conference Schedule
Printable Program_2019 PGM Conference.pdf
8:30 Registration/Vendor Exhibits/Continental Breakfast
9:00 Welcoming Remarks:
Patricia Winokur, MD; Richard Smith, MD
9:15 Session 1: Maternal and Fetal Medicine in Precision Medicine
- Keynote Speaker: David Goldstein, PhD
- Preimplantation genetic diagnosis and case study
E. Hakan Duran, MD/Rachel Whynott, MD - Cell-free DNA screening
Mary-Kayt Jones, MS, CGC - Preeclampsia biomarkers
Mark Santillan, MD, PhD - Pregnancy outcomes and genetics
Andrea Greiner, MD - Ethical considerations in prenatal screening
Anya Prince, JD - Panel discussion
11:45 Lunch (provided)
1:15 Session 2: Neurology and Epilepsy
- Keynote Speaker: David Goldstein, PhD
- Copy number variation in autism
Ted Abel, PhD - MRI biomarkers in myotonic dystrophy type 1 (DM1)
Peg Nopoulos, MD - Improved interpretation of genomic testing for developmental disorders using natural language processing-based phenome extraction from the electronic medical record
Ben Darbro, MD, PhD
2:45 Break
3:00 Session 3: Drugs and the Genome
- Reading a pharmacogenetics report
Colleen Campbell, PhD, MS, CGC - Pharmacogenetic screening for pediatric cancer patients
Jason Cleppe, PharmD - Pharmacogenetic screening for transplant patients
Tricia Suarez, PharmD - Using pharmacogenomics in psychiatric conditions: how can we move forward?
Jordan Schultz, PharmD - Drug repositioning
Morgan Sturgeon, Graduate Student
4:40 Summary and adjourn
Anne Kwitek, PhD
Disclosure Policies:
Determination of educational content for this program and the selection of speakers are responsibilities of the program director and planning committee. Firms providing financial support did not have input in these areas. Individuals with disabilities are encouraged to attend all University of Iowa-sponsored events. If you are a person with a disability who requires an accommodation in order to participate in this program, please contact the Iowa Institute of Human Genetics (IIHG) at 319-335-3688.
Everyone in a position to control the content of this educational activity will disclose to the CE provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA).
The University of Iowa prohibits discrimination in employment, educational programs, and activities on the basis of race, creed, color, religion, national origin, age, sex, pregnancy, disability, genetic information, status as a U.S. veteran, service in the U.S. military, sexual orientation, gender identity, associational preferences, or any other classification that deprives the person of consideration as an individual. The university also affirms its commitment to providing equal opportunities and equal access to university facilities. For additional information on nondiscrimination policies, contact the Director, Office of Equal Opportunity and Diversity, the University of Iowa, 202 Jessup Hall, Iowa City, IA, 52242-1316, 319-335-0705 (voice), 319-335-0697 (TDD), diversity@uiowa.edu.
Individuals with disabilities are encouraged to attend all University of Iowa-sponsored events. If you are a person with a disability who requires an accommodation in order to participate in this program, please contact the Iowa Institute of Human Genetics in advance at 319-335-3688.